Lilly (Eli) & Co : Re European Rights to Pfizer Animal Health Assets

Related articles

• 4 months
  after
  • Pfizer Announces European Union Approval Of A New Form Of Lipitor (atorvastatin) For Use In Children - Medical News Today
  
  
• 3 months
  after
  • 150,000 Pounds Fake Drug Stash Seized In Sting Operation, UK - Medical News Today
  
  
• Selected Article Lilly (Eli) & Co : Re European Rights to Pfizer Animal Health Assets - Investegate
• 1 week
  before
  • Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia - Medical News Today
  • Pharma groups team up on cancer research - Financial Times - ...
  • Big three US firms set up Asian cancer venture - PharmaTimes
  
  
• 1 month
  before
  • Government Cracks Down On Drug Marketing - Medical News Today
  • Pfizer And Auxilium Announce Commencement Of European Regulatory Review Of XIAFLEXTM For The Treatment Of Dupuytren's Contracture - Medical News Today
  • Pfizer/Auxilium’s contracted hand drug set for EU review - PharmaTimes
  • European Medicines Agency's COMP Adopts Positive Opinion For The Orphan Drug Designation For Protalix's Taliglucerase Alfa - Medical News Today
  • European Commission Approves New Intravenous Formulation Of Pfizer's Revatio(R) (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension - Medical News Today
  
  
• 2 months
  before
  • Chi-Med's eastern promise | Nils Pratley - The Guardian - ...
  • Lilly heads flurry of pharma licensing agreements - PharmaTimes
  • Pfizer Receives European Authorization For Prevenar 13 For The Prevention Of Pneumococcal Disease In Infants And Young Children - Medical News Today
  • Takeda and Pfizer team up in China - PharmaTimes
  
  
• 3 months
  before
  • Pharmacos fined in ED drugs price fix - PharmaTimes
  • Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA) - Medical News Today
  
  
• 5 months
  before
  • Novartis International AG : Novartis gains exclusive wo... - Investegate
  • NOVARTIS AG CHF0.50(REGD) : Novartis gains exclusive wo... - Investegate
  • Drug firms buy vaccine-makers: Shot in the dark - The Economist - ...
  • Wyeth Receives Positive Opinion From European Regulators For Its 13-valent Pneumococcal Candidate Vaccine For Infants And Young Children - Medical News Today
  
  
• 7 months
  before
  • NicOx buys back glaucoma drug rights from Pfizer - PharmaTimes
  • Pharmaceuticals earnings boost - Financial Times - ...
  • Pfizer profits hit by lower sales - Financial Times - ...
  • Pfizer Receives Approval From European Commission For Pending Acquisition Of Wyeth - Medical News Today